Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.
Industry News

eXmoor Pharma and Anthony Nolan Cell Therapy and Laboratory Services to offer end-to-end support for cell therapy developers
Sep 2, 2025
Industry News

eXmoor Pharma Strengthens Leadership Team with New CEO Appointment
Jul 8, 2025
Industry News

eXmoor Pharma and Signadori Bio launch partnership to develop next-generation monocyte-based cell therapy for solid tumours
Jun 17, 2025
Industry News

eXmoor Pharma and KU Leuven announce strategic partnership to accelerate cell and gene therapy innovation through new venture
May 13, 2025
Industry News

eXmoor Pharma Strengthens Board with Appointment of Dr James Miskin as Non-Executive Director
Apr 1, 2025
Industry News

eXmoor and Virica receive funding to improve AAV gene therapy manufacturing
Oct 17, 2024
Industry News

Quell Therapeutics Expands Manufacturing Capabilities for CAR-Treg Cell Therapy Pipeline Through Partnership
Sep 24, 2024
Industry News

eXmoor Pharma’s GMP cell and gene therapy manufacturing facility receives license from MHRA
Aug 20, 2024
Industry News

eXmoor appoints Matthew Paterson as first Chief Commercial Officer
Nov 16, 2023
Industry News
1
2